ChartMillOctober 21, 2026 at 8:21 AM NY6 Days Ago
Abbott Laboratories (NYSE:ABT) Posts In-Line Q3 Results as Reaffirmed Guidance and Nutrition Separation Pressure Shares
Abbott Q3 2026 results were in line, with slight revenue and EPS misses, reaffirmed guidance, Nutrition separation plans, and shares down 4.3% premarket.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill
